Bio-techne news
Web2 days ago · MINNEAPOLIS, April 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 3, 2024, at 8:00 a.m. CDT to review third quarter 2024 financial results.. Access to the discussion may be obtained as follows: WebJan 5, 2024 · MINNEAPOLIS and MARLBOROUGH, Mass., Jan. 5, 2024 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced …
Bio-techne news
Did you know?
WebMar 1, 2024 · About Bio-Techne. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities ... WebApr 20, 2016 · Bio-Techne News & Media. BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA™ INSTRUMENTS NOW IN OPERATION MINNEAPOLIS, April 5, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated …
WebMar 1, 2024 · Bio-Techne’s $257 million investment will give the Company a 20% ownership stake in Wilson Wolf. The agreement includes the right to acquire the remaining ownership in Wilson Wolf for $1 billion upon its achievement of $226 million in trailing 12-month revenue or $136 million in EBITDA. If the remaining milestone is not met by … WebAug 4, 2024 · MINNEAPOLIS, Aug. 4, 2024 /PRNewswire/ -- Bio-Teche Corporation (NASDAQ: TECH) today announced Chuck Kummeth's planned two-year transition from …
Web1 day ago · Bio-Techne Corp. is expanding into the realm of diagnostics with its ExoDx Prostate cancer test and a development pipeline of comparable products — a new area … WebApr 10, 2024 · Financial Performance. In 2024, Bio-Techne's revenue was $1.11 billion, an increase of 18.75% compared to the previous year's $931.03 million. Earnings were $272.05 million, an increase of 93.75%. Financial Statements.
Web1 day ago · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions …
WebDec 5, 2024 · Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic … fourseenWeb1 day ago · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … four sedanWebCompare with up to 5 Stocks. On Monday morning 04/03/2024 the Bio-Techne Corp share started trading at the price of $73.72. Compared to the closing price on Friday 03/31/2024 on NAS of $74.19 ... discounted six flags tickets 2022WebBio-Techne announces launch of Cultrex™ UltiMatrix BME to support organoid and pluripotent stem cell cultures. Learn More About Cultrex UltiMatrix. Bio-Techne announces ISO 9001-2015 certification for its … foursee agWebCompare with up to 5 Stocks. On Monday morning 04/03/2024 the Bio-Techne Corp share started trading at the price of $73.72. Compared to the closing price on Friday … discounted six flags over georgia ticketsWebMar 27, 2024 · Bio-Techne maintained stable EBIT margins over the last year, all while growing revenue 8.8% to US$1.1b. That's progress. The chart below shows how the … fourseen monitorWebBio-Techne Corp. Analyst Report: Bio-Techne Corp Based in Minneapolis, Bio-Techne develops and markets protein-based instruments and reagents for research and clinical … fourseen wallet